Subcutaneous injection of TAK-850
TAK-850/CPH-002
Phase 2 small_molecule completed
Quick answer
Subcutaneous injection of TAK-850 for Influenza Infection is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Influenza Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed